EUVIMEDEUVIMED entdecken
Crossref

DRML-Ensemble: drug repurposing method based on feature construction of multi-layer ensemble

Mengfei Zhang, Hongjian He, Jiang Xie, Qing Nie

Journal of Molecular Modeling · 2024

DOI: 10.1007/s00894-024-06087-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Modeling, 2024. Verfasst von Mengfei Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shanghai University, Shanghai, 200444, China. Hauptthemen laut MEDLINE: Drug Repositioning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CONTEXT: Computational drug repurposing methods have been continuously developed in recent years to alleviate the high costs associated with drug development. As drug targets or the products of disease-related genes, proteins play an important role in drug repurposing. Although the potential has been demonstrated, heterogeneous graphs with proteins as independent nodes have yet to be studied, where extracting high-quality protein features from heterogeneous graphs poses a significant challenge. A novel drug repurposing model based on the feature construction of multi-layer ensemble (DRML-Ensemble) is proposed in this study. The performance of DRML-Ensemble, as evaluated on publicly available datasets, achieves an AUPR value of 0.93 and an AUROC value of 0.92, surpassing those of existing state-of-the-art methods. Additionally, DRML-Ensemble demonstrates its notable ability for drug repurposing in Alzheimer's disease. METHODS: DRML-Ensemble is primarily composed of multiple layers of heterogeneous graph feature construction (HGFC). Each HGFC can extract protein features by leveraging the relationships between drugs, diseases, and proteins. These protein features are then utilized in subsequent layers to build drug and disease features, facilitating drug repurposing. By stacking multiple layers, optimal protein features can be obtained from the heterogeneous graph, consequently improving the accuracy of drug repurposing. However, an excessive· stacking of layers usually affect the model's training process, for example, causing problems such as overfitting; a multi-layer ensemble prediction module is designed to further improve the model's performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningHumansProteinsComputational BiologyAlgorithmsAlzheimer Disease

Stichwörter der Autor:innen

Drug repurposingHeterogeneous graphMulti-layer ensembleProtein feature construction

Substanzen

Proteins

Autor:innen und Institutionen

  • School of Medicine, Shanghai University, Shanghai, 200444, China.
  • School of Computer Engineering and Science, Shanghai University, Shanghai, 200444, China.
  • School of Computer Engineering and Science, Shanghai University, Shanghai, 200444, China. jiangx@shu.edu.cn.
  • Department of Mathematics, Department of Developmental and Cell Biology, University of California, Irvine, CA, 92697-3875, USA. qnie@uci.edu.

Zitieren

APA

Zhang, M., He, H., Xie, J., & Nie, Q. (2024). DRML-Ensemble: drug repurposing method based on feature construction of multi-layer ensemble. Journal of Molecular Modeling. https://doi.org/10.1007/s00894-024-06087-9

Vancouver

Zhang M, He H, Xie J, Nie Q. DRML-Ensemble: drug repurposing method based on feature construction of multi-layer ensemble. Journal of Molecular Modeling. 2024. doi:10.1007/s00894-024-06087-9

BibTeX
@article{Zhang2024,
  author = {Zhang, Mengfei and He, Hongjian and Xie, Jiang and Nie, Qing},
  title = {DRML-Ensemble: drug repurposing method based on feature construction of multi-layer ensemble},
  journal = {Journal of Molecular Modeling},
  year = {2024},
  doi = {10.1007/s00894-024-06087-9}
}
Kostenlos starten →